Long-term renal survival in malignant hypertension.

Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain.
Nephrology Dialysis Transplantation (Impact Factor: 3.37). 03/2010; 25(10):3266-72. DOI: 10.1093/ndt/gfq143
Source: PubMed

ABSTRACT Some studies have shown an improvement in the prognosis of patients with essential malignant hypertension (MHT), but data about long-term outcome and prognostic factors of these patients are scarce.
We performed a single-centre retrospective analysis of 197 patients with MHT, diagnosed in the period 1974-2007.
Incidence of MHT remained stable along the different periods of the study. Renal damage at presentation was common (63% of patients) but renal function improved or remained stable after diagnosis in a majority of patients. The probability of renal survival was 84 and 72% after 5 and 10 years, respectively. Diagnosis during the first period (1974-85) of the study, previous chronic renal impairment, baseline renal function and proteinuria, presence of microhaematuria, systolic and diastolic blood pressure and proteinuria during follow-up were associated with an unfavourable outcome. By multivariate analysis, mean proteinuria during follow-up remained as the only significant risk factor (OR, 2.72; 95% CI, 1.59-4.64). Renal survival for patients with mean proteinuria <0.5 g/24 h was 100 and 95% after 5 and 10 years, respectively. The number of patients who improved or stabilized their renal function significantly increased in the second and third periods of the study (1987-2007).
Renal survival in MHT has improved in recent years. Mean proteinuria during follow-up is a fundamental prognostic factor for renal survival.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Malignant hypertension (MHT) is an uncommon clinical manifestation of IgA Nephropathy (IgAN). Its prevalence, pathogenesis and evolution are not well known. Material and methods: We performed a descriptive and retrospective study to report the clinical characteristics and evolution of thirteen patients diagnosed as having IgA nephropathy by renal biopsy in our hospital who developed MHT (IgAN-MHT). Results: The prevalence of MHT in our IgAN patients was 7% (13/186). The mean age was 37±12 years and 84% were males. Mean systolic/diastolic blood pressure at presentation were 219±32/132±18mmHg, respectively. Renal function impairment was detected at admission in all the patients, with a mean serum creatinine of 4.73±3.12mg/dL. No patient showed analytical data that suggested thrombotic microangiopathy. Renal biopsies showed mild chronicity lesions and only four patients presented features of thrombotic microangiopathy. All patients were treated with renin-angiotensin-aldosterone blockers and two received steroids. They all showed a progressive loss of renal function. At the end of follow up one patient had died, ten were on chronic dialysis and two presented chronic kidney disease stage 3b. Renal survival was 69% and 35% at 3 and 6 years, respectively. Six patients received a kidney transplant: IgAN relapsed in four patients. One of them presented a new episode of MHT associated with a HELLP syndrome. Conclusions: Malignant hypertension is a form of IgAN clinical presentation having a remarkably worse renal outcome and without specific effective treatment.
    Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia 01/2015; 35(1):42-49. DOI:10.3265/Nefrologia.pre2014.Oct.12735 · 1.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Most patients with essential hypertension do not exhibit substantial renal damage. Renal autoregulation by preventing glomerular transmission of systemic pressures has been postulated to mediate this resistance. Conversely, malignant nephrosclerosis (MN) has been postulated to develop when severe hypertension exceeds a critical ceiling. If the concept is valid, even modest blood pressure (BP) reductions to below this threshold regardless of antihypertensive class (1) should prevent MN and (2) lead to the healing of the already developed MN lesions. Both predicates were tested using BP radiotelemetry in the stroke-prone spontaneously hypertensive rats receiving 1% NaCl as drinking fluid for 4 weeks. Severe hypertension (final 2 weeks average systolic BP, >200 mm Hg) and MN (histological damage score 36±5; n=27) developed in the untreated stroke-prone spontaneously hypertensive rats but were prevented by all antihypertensive classes (enalapril [n=15], amlodipine [n=13], or a hydralazine/hydrochlorothiazide combination [n=15]) if the final 2-week systolic BP remained <190 mm Hg. More impressively, modest systolic BP reductions to 160 to 180 mm Hg (hydralazine/hydrochlorothiazide regimen) initiated at ≈4 weeks in additional untreated rats after MN had already developed (injury score 35±4 in the right kidney removed before therapy) led to a striking resolution of the vascular and glomerular MN injury over 2 to 3 weeks (post-therapy left kidney injury score 9±2, P<0.0001; n=27). Proteinuria also declined rapidly from 122±9.5 mg/24 hours before therapy to 20.5±3.6 mg 1 week later. These data clearly demonstrate the barotrauma-mediated pathogenesis of MN and the striking capacity for spontaneous and rapid repair of hypertensive kidney damage if new injury is prevented.
    Hypertension 06/2014; 64(4). DOI:10.1161/HYPERTENSIONAHA.114.03609 · 7.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypertensive crises are defined as acute blood pressure elevations that can cause functional or structural alterations in hypertension target organs. Historically, they have been divided into two types, urgencies and hypertensive emergencies, with different symptoms, treatment and prognosis. This review follows this classification but also considers a third type, the so-called pseudocrises or false hypertensive crisis. Hypertensive urgencies do not cause organ involvement target or if this does occur, the involvement is slight-moderate, allowing a slow and progressive decrease in pressure (hours-days) with oral drugs usually in the outpatient setting (primary care). Hypertensive emergencies cause acute and severe injuries of the target organs, with life threatening risk, and require a rapid, but very controlled drop with intravenous drugs in blood pressure (minutes-hours) within the hospital setting. Acute blood pressure elevations that cannot be classified as urgencies or emergencies are considered hypertensive pseudocrises.
    Hipertensión y Riesgo Vascular 05/2014; DOI:10.1016/j.hipert.2014.04.001

Full-text (2 Sources)

Available from
May 29, 2014